Europe Novel Drug Delivery Systems Market Size & Share Analysis - Growth Trends & Forecasts (2025 - 2030)

The Europe NDDS Market is segmented by Route of Administration, Mode of NDDS (Targeted Drug Delivery Systems, Controlled Drug Delivery Systems, and Modulated Drug Delivery Systems), and Geography.

Europe Novel Drug Delivery Systems Market Size

View Global Report

Europe Novel Drug Delivery Systems Market Analysis

The Europe Novel Drug Delivery System Market is expected to register a CAGR of 8.1% during the forecast period.

European novel drug delivery system market primarily driven by technological advancements promoting the development of NDDS and the rising need for controlled release of drugs.

Nowadays, for the treatment of chronic disorders as well as for controlling the release of active ingredients from drug products, a unique delivery system, the controlled release drug delivery system (CRDDS) of novel drug delivery, is included in the drug delivery technique. Majority of the active pharmaceutical ingredients are distributed in the form of CRDDS. A controlled drug delivery system is, thus, a very reliable, potential form of novel drug delivery technique, in which the drug is subjected to the appropriate pharmaceutical drug dosage form and its release is predetermined, making the release controlled at particular sites of action (cells, tissues, and organs).

Transdermal patches, implants, nasal systems, microcapsules, etc., are some of the common systems that are considered under controlled release systems. The need for controlled release of drugs is propelling the increasing demand for unique and innovative systems for drug delivery, where this novel drug delivery system plays a significant role in the advancement of controlled release of drugs, thereby driving the growth of the market, over the forecast period.

Europe Novel Drug Delivery Systems Industry Overview

The market comprises major market players who are primarily focused on research and development for the creation of a stable and safe formulation. The market has been experiencing technological developments on a large scale for the past couple of years. Some of the market players are Abbott Laboratories, AstraZeneca PLC, Bayer AG, GlaxoSmithKline PLC, Novartis AG, Pfizer Inc., F. Hoffmann-La Roche AG, and Sanofi SA.

Europe Novel Drug Delivery Systems Market Leaders

  1. GlaxoSmithKline PLC

  2. Pfizer Inc.

  3. Sanofi SA

  4. AstraZeneca

  5. Novartis AG

  6. *Disclaimer: Major Players sorted in no particular order
Need More Details on Market Players and Competitors?
Download PDF

Europe Novel Drug Delivery Systems Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Deliverables
  • 1.2 Study Assumptions
  • 1.3 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Technological Advancements Promoting the Development of NDDS
    • 4.2.2 Rising Need for the Controlled Release of Drugs
  • 4.3 Market Restraints
    • 4.3.1 Stringent Regulatory Guidelines
    • 4.3.2 Stability Issues
  • 4.4 Porter's Five Forces Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION

  • 5.1 By Route of Administration
    • 5.1.1 Oral Drug Delivery Systems
    • 5.1.2 Injectable Drug Delivery Systems
    • 5.1.3 Pulmonary Drug Delivery Systems
    • 5.1.4 Transdermal Drug Delivery Systems
    • 5.1.5 Other Routes of Administration
  • 5.2 By Mode of NDDS
    • 5.2.1 Targeted Drug Delivery Systems
    • 5.2.2 Controlled Drug Delivery Systems
    • 5.2.3 Modulated Drug Delivery Systems
  • 5.3 Geography
    • 5.3.1 Europe
    • 5.3.1.1 United Kingdom
    • 5.3.1.2 Germany
    • 5.3.1.3 France
    • 5.3.1.4 Italy
    • 5.3.1.5 Spain
    • 5.3.1.6 Rest of Europe

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Abbott Laboratories
    • 6.1.2 AstraZeneca PLC
    • 6.1.3 Bayer AG
    • 6.1.4 GlaxoSmithKline PLC
    • 6.1.5 Johnson & Johnson
    • 6.1.6 Merck & Co. Inc.
    • 6.1.7 Novartis AG
    • 6.1.8 Pfizer Inc.
    • 6.1.9 F. Hoffmann-La Roche AG
    • 6.1.10 Sanofi SA
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Europe Novel Drug Delivery Systems Industry Segmentation

As per the scope of this report, novel drug delivery system refers to the approaches, technologies, systems, and formulations for transporting a pharmaceutical compound in the body as required to safely achieve its desired therapeutic effects. It is a novel system for the delivery of drugs, different from the conventional drug delivery systems. The market is segmented by route of administration, mode of NDDS, and geography.

 

By Route of Administration Oral Drug Delivery Systems
Injectable Drug Delivery Systems
Pulmonary Drug Delivery Systems
Transdermal Drug Delivery Systems
Other Routes of Administration
By Mode of NDDS Targeted Drug Delivery Systems
Controlled Drug Delivery Systems
Modulated Drug Delivery Systems
Geography Europe United Kingdom
Germany
France
Italy
Spain
Rest of Europe
By Route of Administration
Oral Drug Delivery Systems
Injectable Drug Delivery Systems
Pulmonary Drug Delivery Systems
Transdermal Drug Delivery Systems
Other Routes of Administration
By Mode of NDDS
Targeted Drug Delivery Systems
Controlled Drug Delivery Systems
Modulated Drug Delivery Systems
Geography
Europe United Kingdom
Germany
France
Italy
Spain
Rest of Europe
Need A Different Region or Segment?
Customize Now

Europe Novel Drug Delivery Systems Market Research FAQs

What is the current Europe Novel Drug Delivery System (NDDS) Market size?

The Europe Novel Drug Delivery System (NDDS) Market is projected to register a CAGR of 8.1% during the forecast period (2025-2030)

Who are the key players in Europe Novel Drug Delivery System (NDDS) Market?

GlaxoSmithKline PLC, Pfizer Inc., Sanofi SA, AstraZeneca and Novartis AG are the major companies operating in the Europe Novel Drug Delivery System (NDDS) Market.

What years does this Europe Novel Drug Delivery System (NDDS) Market cover?

The report covers the Europe Novel Drug Delivery System (NDDS) Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Europe Novel Drug Delivery System (NDDS) Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Page last updated on: June 16, 2024

Europe NDDS Industry Report

Statistics for the 2025 Europe Novel Drug Delivery System (NDDS) market share, size and revenue growth rate, created by Mordor Intelligenceâ„¢ Industry Reports. Europe Novel Drug Delivery System (NDDS) analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.

Europe NDDS Market Report Snapshots